Sunitinib Malate FDA approval date

The FDA approved Sunitinib Malate (Sutent®) on 26 Jan 2006.

FDA approval date
26 Jan 2006

Drug identity checked against registry records

Also recorded as Sutent®

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell CarcinomaNCT05678673ExelixisPhase 3Active not recruiting2026-12-15Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2006-01-26DaySunitinib MalateFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021938", "applicant_as_listed_by_fda": "CPPI CV", "brand_names": ["SUTENT"], "active_ingredients": ["SUNITINIB MALATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060126", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026